Idexx Laboratories (IDXX) 111.83 $IDXX Ride the Momentum

New Post Public Reply Private Reply Replies (0) Message Board

Sep 21, 2016 at 1:06 AM

Idexx Laboratories (IDXX) 111.83 $IDXX

Ride the Momentum with These 4 Fast-Moving Stocks
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:48AM CDT
This screen will help you to get into momentum stocks that are storming ahead. Highlighted stocks include HL, UFPI, IDXX and MTZ.
HL: 5.67 (+0.08), IDXX: 111.83 (+1.19), UFPI: 100.43 (+0.16), MTZ: 27.53 (-1.00)

LeMaitre Hits 52-Week High on Strong International Presence
Zacks Equity Research - Zacks Investment Research - Wed Sep 14, 7:49AM CDT
Share price of Burlington, MA-based LeMaitre Vascular, Inc. (LMAT) reached a new 52-week high of $21.20 on Sep 13, eventually closing a bit lower at $20.39.
MASI: 59.31 (-0.53), LMAT: 21.78 (+0.06), LNTH: 8.50 (+0.05), IDXX: 111.83 (+1.19)

Shares of IDXX Up 52.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Sep 13, 2:19PM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 7 months, Idexx Laboratories has returned 52.58% as of today's recent price of $109.51.
IDXX: 111.83 (+1.19)

Acadia & Ochsner Form Partnership, Announce New Facility
Zacks Equity Research - Zacks Investment Research - Tue Sep 13, 7:33AM CDT
Acadia Healthcare (ACHC) recently announced a strategic partnership with Ochsner Health System to set up an 82-bed acute psychiatric hospital, scheduled to open in 2018.
ACHC: 50.20 (-0.83), MASI: 59.31 (-0.53), IDXX: 111.83 (+1.19), NUVA: 66.89 (+0.36)

Varian (VAR) Acquires Radiotherapy Business of Candela
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 10:01AM CDT
Varian Medical Systems (VAR) recently announced the acquisition of the radiotherapy business of Candela.
MASI: 59.31 (-0.53), VAR: 96.01 (-0.04), IDXX: 111.83 (+1.19), CRY: 17.86 (unch)

STERIS Poised on Synergy Health Addition amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Thu Sep 08, 8:18AM CDT
On Sep 8, we issued an updated research report on OH-based STERIS plc (STE).
MASI: 59.31 (-0.53), STE: 72.82 (+1.07), IDXX: 111.83 (+1.19), CRY: 17.86 (unch)

Cepheid (CPHD) Gets FDA Clearance for Xpert TV Assay
Zacks Equity Research - Zacks Investment Research - Wed Sep 07, 9:23AM CDT
Cepheid (CPHD) recently received an approval for its Xpert TV assay from the U.S. FDA.
MASI: 59.31 (-0.53), CPHD: 52.49 (-0.07), IDXX: 111.83 (+1.19), CRY: 17.86 (unch)

Ensign Group (ENSG) Acquires Kinder Hearts, Grows in Texas
Zacks Equity Research - Zacks Investment Research - Wed Sep 07, 9:15AM CDT
The Ensign Group, Inc. (ENSG) recently announced that Cornerstone Healthcare, its home health and hospice portfolio subsidiary, has acquired Abilene, TX-based Kinder Hearts Home Health and Hospice.
ENSG: 20.95 (-0.05), MASI: 59.31 (-0.53), IDXX: 111.83 (+1.19), CRY: 17.86 (unch)

IDEXX Laboratories to Present at Raymond James North American Equities Conference
PR Newswire - Tue Sep 06, 1:01PM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the Raymond James 12th Annual North American Equities Conference. Michael Williams, PhD, Executive Vice President, is scheduled to make a presentation on the Company on Tuesday, September 13, 2016 at 12:45 p.m. BST/7:45 a.m. EDT, at the Four Seasons Hotel London at Park Lane, London, England. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archive of the presentation will be available via the same link.
IDXX: 111.83 (+1.19)

Uptrend Call Working As Idexx Laboratories Stock Rises 59.0% (IDXX)
Comtex SmarTrend(R) - Tue Sep 06, 12:20AM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 7 months, Idexx Laboratories has returned 58.97% as of today's recent price of $114.09.
IDXX: 111.83 (+1.19)

Globus Medical (GMED) Closes Alphatec Buyout, Stock Gains
Zacks Equity Research - Zacks Investment Research - Mon Sep 05, 8:18AM CDT
Globus Medical, Inc. (GMED) recently completed the acquisition of Alphatec Holdings, which was announced earlier in July.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), GMED: 22.21 (-0.16), IDXX: 111.83 (+1.19)

St. Jude Medical (STJ) Launches Trial for Amulet Occluder
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:54AM CDT
St. Jude Medical, Inc. (STJ), a global medical device company, announced that it has initiated a trial for its AMPLATZER Amulet occlude.
MASI: 59.31 (-0.53), QDEL: 22.91 (+0.60), STJ: 78.89 (-0.15), IDXX: 111.83 (+1.19)

The Cooper Companies (COO) Beats Q3 Earnings, View Up
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:27AM CDT
The Cooper Companies Inc. (COO) reported adjusted earnings of $2.30 in the third quarter of 2016, beating the Zacks Consensus Estimate by 2 cents and improving 16.8% on a year-over-year basis.
BABY: 43.20 (+0.24), QDEL: 22.91 (+0.60), IDXX: 111.83 (+1.19), COO: 186.41 (-2.06)

FEI Shareholders Approve Thermo Fisher Deal (Revised)
Urmimala Biswas - Zacks Investment Research - Thu Sep 01, 4:44PM CDT
Shareholders of FEI recently approved mega $4.2 billion deal to be acquired by Thermo Fisher Scientific.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), TMO: 151.62 (+1.62), IDXX: 111.83 (+1.19)

Thermo Fisher Shareholders Approve FEI Deal, Grows in Electron Microscopy (Revised)
Urmimala Biswas - Zacks Investment Research - Thu Sep 01, 2:59PM CDT
Shareholders of Thermo Fisher recently approved its previously announced mega $4.2 billion acquisition of FEI Company.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), TMO: 151.62 (+1.62), IDXX: 111.83 (+1.19)

Henry Schein to Buy Marrodent Stake, Expand in Poland
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 8:48AM CDT
Keeping in line with its strategy of growth through rapid expansion internationally, Henry Schein Inc (HSIC) has agreed to acquire 80% ownership of Marrodent.
MASI: 59.31 (-0.53), QDEL: 22.91 (+0.60), IDXX: 111.83 (+1.19), HSIC: 162.80 (+0.32)

Thermo Fisher Closes FEI Deal, Grows in Electron Microscopy
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 6:42AM CDT
Thermo Fisher Scientific, Inc. (TMO) recently completed its earlier announced mega $4.2 billion acquisition of FEI Company.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), TMO: 151.62 (+1.62), IDXX: 111.83 (+1.19)

Why IDEXX Laboratories (IDXX) is Poised to Beat Earnings Estimates (Again)
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 9:08AM CDT
IDEXX Laboratories (IDXX) has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
IDXX: 111.83 (+1.19)

Varian Medical Excels on Growing International Footprint
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:46AM CDT
Varian recently announced the installation of a Clinac iX medical linear accelerator at Instituto Oncologico del Oriente Boliviano in Santa Cruz, Bolivia.
MASI: 59.31 (-0.53), VAR: 96.01 (-0.04), QDEL: 22.91 (+0.60), IDXX: 111.83 (+1.19)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking the Code of America's Delivery Addiction

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

FutureVault's AI Agents: Transforming Financial Workflows

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Machine Grabs Prime Dallas Property Amid Apartment Boom

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Succession Planning in Turmoil: Only 42% Ready

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Leapora's Taskeen: Redefining Task Accountability

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Davos Healthcare Aims to Revolutionize Hospital Ratings

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

AI-Driven Lumi Transforms Car Dealership Interactions

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...